Does VALSARTAN Cause Interstitial lung disease? 98 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 98 reports of Interstitial lung disease have been filed in association with VALSARTAN (valsartan). This represents 0.5% of all adverse event reports for VALSARTAN.
98
Reports of Interstitial lung disease with VALSARTAN
0.5%
of all VALSARTAN reports
13
Deaths
69
Hospitalizations
How Dangerous Is Interstitial lung disease From VALSARTAN?
Of the 98 reports, 13 (13.3%) resulted in death, 69 (70.4%) required hospitalization, and 1 (1.0%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VALSARTAN. However, 98 reports have been filed with the FAERS database.
What Other Side Effects Does VALSARTAN Cause?
Drug ineffective (1,845)
Blood pressure increased (1,682)
Dizziness (1,527)
Headache (1,361)
Hypertension (1,341)
Acute kidney injury (1,301)
Dyspnoea (1,239)
Fatigue (1,156)
Malaise (1,139)
Hypotension (1,032)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which VALSARTAN Alternatives Have Lower Interstitial lung disease Risk?
VALSARTAN vs VALTREX
VALSARTAN vs VAMOROLONE
VALSARTAN vs VANCOMYCIN
VALSARTAN vs VANDETANIB
VALSARTAN vs VARDENAFIL